Synergy Pharma

We’re igniting change in gastrointestinal (GI) medicine to develop new treatments with the potential to improve the lives of patients.

[Synergy Pharma @SynergyPharma]

At #ACG2018, Synergy Pharmaceuticals will present outcomes from a post-hoc analysis of two trials which studied the safety and efficacy of a treatment for CIC in patients receiving concomitant acid suppression therapy. Find out more here: https://t.co/g61RxmUo7E $SGYP #ACG2018

[Synergy Pharma @SynergyPharma]

At #ACG2018, Synergy Pharmaceuticals will present outcomes from post-hoc analyses of trials which studied adult patients ≥65, a group in which constipation is prevalent and there are limited data. Find out more on these analyses here: https://t.co/Kn1y5fTcVr $SGYP #ACG2018

[Synergy Pharma @SynergyPharma]

Synergy Pharmaceuticals to present new analyses that further reinforce effectiveness and safety in important subpopulations of adults with CIC or IBS-C at the @AmCollegeGastro Annual Scientific Meeting next week. More info: https://t.co/jrA82mkPZT $SGYP #ACG2018

[Synergy Pharma @SynergyPharma]

Synergy Pharmaceuticals announces new formulary wins improving 2018 and 2019 coverage status across major U.S. Commercial, Medicare Part D and Managed Medicaid plans. Read the full press release: https://t.co/oUie8jCgyp $SGYP

[Synergy Pharma @SynergyPharma]

Synergy Pharmaceuticals reports Q2 2018 financial and business results. Read the update: https://t.co/Nk1yJWzsZH $SGYP

[Synergy Pharma @SynergyPharma]

Synergy Pharmaceuticals announces major coverage win with @ExpressScripts. Get the details: https://t.co/PlQ4XrAiAB $SGYP

[Synergy Pharma @SynergyPharma]

Synergy Pharmaceuticals secures licensing deal in China with Luoxin Pharmaceutical Group Co., Ltd. Read more: https://t.co/YeITcXmLeR $SGYP

[Synergy Pharma @SynergyPharma]

Synergy Pharmaceuticals presents new data at Digestive Disease Week. Find the details here https://t.co/wpJFiz7br9 @DDWmeeting #DDW2018 $SGYP

[Synergy Pharma @SynergyPharma]

Synergy Pharmaceuticals highlights new data at Digestive Disease Week linking uroguanylin deficiency to CIC and IBS-C. Find the details here https://t.co/FDBXsqwGz2 @DDWmeeting #DDW2018 $SGYP

[Synergy Pharma @SynergyPharma]

Synergy Pharmaceuticals to present new data at Digestive Disease Week. Find the details here https://t.co/CIrRdKBGoK @DDWmeeting #DDW2018 $SGYP

[Synergy Pharma @SynergyPharma]

HAPPENING NOW: Tune in to our live conference call and webcast to hear Synergy management discuss our 1Q 2018 financial and business results: https://t.co/HpVXb55l7j $SGYP

[Synergy Pharma @SynergyPharma]

Synergy reports 1Q 2018 financial and business results. Get the details: https://t.co/6eRzEA1zwi $SGYP

[Synergy Pharma @SynergyPharma]

Synergy to host conference call and webcast to discuss financial and operating results for Q1 2018 on Thursday, 5/10 at 4:30 p.m. EDT. Get the details: https://t.co/pUiaFUHXdJ

[Synergy Pharma @SynergyPharma]

#IBS is the 7th most common diagnosis by primary care physicians in the US, affecting millions of people. Learn more: https://t.co/kxZcZi3heN #IBSAwarenessMonth

[Synergy Pharma @SynergyPharma]

On average, #IBS leads to 2 missed days of school/work and 9 days of impacted productivity each month. #IBSAwarenessMonth

[Synergy Pharma @SynergyPharma]

Nearly 1 in 4 of people living with #IBS report that they cannot accurately predict if they will experience symptoms on any given day. #IBSAwarenessMonth

[Synergy Pharma @SynergyPharma]

April is Irritable Bowel Syndrome (#IBS) Awareness Month. #DYK that 1 in 20 people in the U.S. lives with IBS-C? #IBSAwarenessMonth

[Synergy Pharma @SynergyPharma]

TODAY: Synergy CEO Troy Hamilton to present at the Oppenheimer Healthcare Conference: https://t.co/jhr5KEjyeB $SGYP

[Synergy Pharma @SynergyPharma]

Synergy's Troy Hamilton to present at the Oppenheimer Conference on 3/20. Learn more: https://t.co/YQHGP5HtbH $SGYP

[Synergy Pharma @SynergyPharma]

How many Americans are living with #IBS-C? https://t.co/yz72Z8MBfS